Page last updated: 2024-09-05

sorafenib and pf-4708671

sorafenib has been researched along with pf-4708671 in 2 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(pf-4708671)
Trials
(pf-4708671)
Recent Studies (post-2010) (pf-4708671)
6,5207305,25144042

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)pf-4708671 (IC50)
Ribosomal protein S6 kinase beta-1Homo sapiens (human)0.16

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Choi, HN; Hong, SE; Jin, HO; Kim, EK; Kim, HA; Kim, JH; Lee, JK; Noh, WC; Park, IC1

Other Studies

2 other study(ies) available for sorafenib and pf-4708671

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
Inhibition of S6K1 enhances glucose deprivation-induced cell death via downregulation of anti-apoptotic proteins in MCF-7 breast cancer cells.
    Biochemical and biophysical research communications, 2013, Mar-01, Volume: 432, Issue:1

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Down-Regulation; Female; Gene Knockdown Techniques; Glucose; Humans; Imidazoles; Inhibitor of Apoptosis Proteins; MCF-7 Cells; Myeloid Cell Leukemia Sequence 1 Protein; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Ribosomal Protein S6 Kinases, 70-kDa; Sorafenib; Survivin; TOR Serine-Threonine Kinases

2013